|
|
STING-Activating GM-CSF Secreting Allogeneic Pancreas Tumor Cell Vaccine Therapy
|
1R43CA186424-01
|
$224,878
|
$224,878
|
DUBENSKY, THOMAS
|
ADURO BIOTECH
|
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192976-01
|
$144,556
|
$76,615
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
1R01CA174432-01A1
|
$581,071
|
$581,071
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
DNA Mismatch repair and cancer in murine models
|
5R01CA076329-17
|
$369,167
|
$369,167
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
5R01CA170911-03
|
$336,129
|
$168,065
|
LIBUTTI, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Development of Novel Drugs to Alleviate CPT-11 Toxicity
|
5R01CA161879-03
|
$317,989
|
$317,989
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Par1-substrates responsible for CagA-mediated pathogenesis of Helicobacter pylori
|
5R01CA160790-03
|
$507,202
|
$507,202
|
MUESCH, ANNE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
$23,838
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
|
5R01CA163907-03
|
$336,129
|
$336,129
|
SCHWARTZ, EDWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
1R01CA175495-01A1
|
$346,525
|
$173,263
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
$29,538
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$9,841
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
The Impact of a Targeted CRC Screening Intervention among Latinos in Central PA
|
5K01CA151752-04
|
$137,943
|
$137,943
|
DOMINIC, ORALIA
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
2R44CA161965-03
|
$499,745
|
$499,745
|
LIM, MARK
|
AMBERGEN, INC
|
|
|
Proteome Bead-Display for Discovery of Tumor Antigens
|
5R44CA137948-04
|
$487,788
|
$487,788
|
LIM, MARK
|
AMBERGEN, INC
|
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$283,845
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)
|
1R43CA183280-01A1
|
$224,700
|
$224,700
|
YANG, MENG
|
ANTICANCER, INC.
|
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
1R01CA184820-01
|
$399,474
|
$399,474
|
DUBOIS, RAYMOND
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
|
5R01CA162393-03
|
$564,116
|
$564,116
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$8,913
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
1R01CA181275-01A1
|
$657,290
|
$657,290
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
3R01CA137019-05S1
|
$94,661
|
$47,331
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-05
|
$282,481
|
$141,241
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$468,580
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Advanced Glycation End-Products and Risk of Pancreatic Cancer
|
5R01CA172880-02
|
$620,623
|
$620,623
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Novel targets that are deregulated by loss of PTEN
|
7R01CA108614-08
|
$284,774
|
$284,774
|
JOHNSON, DEBORAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Chimeric Antigen Receptor Modified T Cell Therapy for Pancreatic Cancer
|
1F32CA189423-01
|
$55,094
|
$55,094
|
MOHAMMED, SOMALA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Hepatitis B virus replication and DDB1
|
5R21CA177951-02
|
$165,089
|
$165,089
|
SLAGLE, BETTY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Steroid Receptor Coactivator-2 as a key hepatic tumor suppressor and circadian me
|
5F31CA171350-03
|
$39,876
|
$39,876
|
STASHI, ERIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
|
5U01CA170930-02
|
$597,078
|
$597,078
|
VERSALOVIC, JAMES
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
JC Virus and Human Colorectal Neoplasia
|
5R01CA098572-10
|
$259,352
|
$259,352
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
1R01CA181572-01A1
|
$327,289
|
$327,289
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
1U01CA187956-01
|
$595,990
|
$595,990
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
CpG-ODN Coated Hollow Gold Nanoshells for Photothermal Therapy
|
5R01CA172836-02
|
$332,608
|
$166,304
|
FOSTER, AARON
|
BELLICUM PHARMACEUTICALS, INC.
|
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$10,368
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
1R01CA178017-01A1
|
$378,056
|
$378,056
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-10
|
$321,009
|
$105,933
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
5R01CA170549-03
|
$490,642
|
$166,818
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of c-Cbl in Colon cancer
|
1R01CA175382-01A1
|
$359,494
|
$359,494
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$15,425
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
|
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers
|
5R01CA156186-05
|
$522,335
|
$522,335
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
|
Spectral Markers for Early Detection of Colon Neoplasia
|
5U01CA111257-10
|
$543,670
|
$543,670
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
|
High resolution phase contrast endoscopy
|
1R01CA182939-01A1
|
$354,523
|
$354,523
|
MERTZ, JEROME
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-24
|
$318,393
|
$105,070
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
1R01CA181392-01A1
|
$309,536
|
$309,536
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
|
5R21CA164245-02
|
$197,693
|
$197,693
|
FALLER, DOUGLAS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Innovative approach to cancer detection and treatment monitoring
|
5R21CA172999-02
|
$169,886
|
$169,886
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-03
|
$1,262,499
|
$252,500
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Defining lineage-specific determinants of K-Ras ""addiction"" in human cancers
|
5R00CA149169-05
|
$231,443
|
$152,752
|
SINGH, ANURAG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Dissecting the metastasis suppressor complex to identify colon cancer biomarkers
|
5R21CA165707-02
|
$172,684
|
$172,684
|
THIAGALINGAM, SAM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Total relevant funding to Digestive Diseases for this search: $423,295,398
|
